We are live on ! Find out more
PPBT

Purple Biotech
PPBT

Fund managers haven’t disclosed any holdings of PPBT yet.

PPBT Hedge Fund Activity: Q1 2026 in Review

15 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2026, worth a combined $306K — down 40% from $513K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of PPBT and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 2 added.

The largest buyer was SmartHarvest Portfolios, adding an estimated $72.2K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $102K sold.

  • 15 institutional investors held Purple Biotech (PPBT) as of Q1 2026, down from 19 in Q4 2025.
  • Funds reported $306K of Purple Biotech stock for Q1 2026, down 40% quarter-over-quarter.
  • 2 funds opened new Purple Biotech positions in Q1 2026 and 5 closed out, a net change of -3 holders.
  • The largest Purple Biotech buyer in Q1 2026 was SmartHarvest Portfolios, an estimated $72.2K added.
  • The largest Purple Biotech seller in Q1 2026 was Two Sigma Investments, an estimated $102K sold.

Based on aggregated 13F filings for Q1 2026.